3rd Quarter - Report
BROWN RUDNICK LLP for PRIME THERAPEUTICS
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to specialty pharmacy. Implementation of the Biologics Price Competition and Innovation Act (BPCIA) relating to biosimilar naming.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | — |
| HENRY W MENN | — |
Pharmacy PHA
Issues relating to prescription drug abuse and diversion; HR 4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | — |
| HENRY W MENN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.